Sunday 11 October 2026 Export all SNY data to Excel Powerpack

Sanofi

SNY Healthcare Drug Manufacturers General

Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024. In the quarter to June 2026, revenue grew 17.4%, EPS fell 90.8%, free cash flow fell 45.1% and total debt rose 8.23%, each against the same quarter a year earlier. Dividend growth for three consecutive years.

40.07 0.16 −0.40%

Follow SNY

Alert me

Market cap: $95.9B
P/E: 21.0×
Fwd P/E: —
Dividend yield: 6.05%
F-score: 7/9
Altman Z: 2.50
Beneish M: −2.63
Dividend safety: 58/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Sanofi (SNY) P/E ratio

Alert me on P/E ratio

As of 9 October 2026, Sanofi (SNY) trades at a P/E ratio of 21.0×. Over the past ten years it has ranged from 3.5× (March 2021) to 32.2× (August 2015); the current reading is higher than 63% of that period. That is below the Drug Manufacturers General industry median of 23.6× and below the Healthcare sector median of 22.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/SNY/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Sanofi P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/SNY/metrics/pe-ratio">Sanofi (SNY) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	13.5×	(32.97%)
FY2024	20.1×	(5.22%)
FY2023	21.2×	53.49%
FY2022	13.8×	109.61%
FY2021	6.6×	75.86%
FY2020	3.7×	(71.08%)
FY2019	12.9×	7.79%
FY2018	12.0×	(50.31%)
FY2017	24.2×	20.22%
FY2016	20.1×	(12.31%)

Period	P/E ratio	Change
Jun 2026	22.3×	65.96%
Mar 2026	13.5×	(0.02%)
Dec 2025	13.5×	19.26%
Sep 2025	11.3×	(4.87%)
38 more quarters	Free account

Against its own ten years

Low 3.5× High 32.2×

Ten-year median 15.4×

Current reading's percentile 69

Company	P/E ratio
GILD Gilead Sciences, Inc. compare	n/m
NVO Novo Nordisk A/S compare	9.4×
BMY Bristol Myers Squibb Company compare	13.0×
GSK GSK PLC Sponsored ADR compare	14.5×
SNY Sanofi	21.0×
NVS Novartis AG compare	21.6×
AZN AstraZeneca PLC compare	23.6×
AMGN Amgen Inc. compare	25.6×
PFE Pfizer Inc. compare	37.2×
Drug Manufacturers General industry median	23.6×
Healthcare sector median	22.5×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Sanofi (SNY) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on SNY

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on SNY

Stockrow Weekly